Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to evaluate the hypothesis that bisphosphonate treatment given
to growth hormone deficient patients (regardless of current growth hormone replacement
therapy status and without changing that status) significantly increases total body bone
mineral density during an eighteen month period of treatment combined with calcium and
Vitamin D when compared to calcium and Vitamin D treatment alone.
Phase:
N/A
Details
Lead Sponsor:
State University of New York - Upstate Medical University